Literature DB >> 4742498

Phase I study of ICRF-159 (NSC-129943) in human solid tumors.

R E Bellet, M J Mastrangelo, L M Dixon, J W Yarbro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4742498

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN： 0069-0112


× No keyword cloud information.
  1 in total

1.  ICRF-159 enhancement of radiation response in combined modality therapies. II. Differential responses of tumour and normal tissues.

Authors:  C J Kovacs; M J Evans; D R Burholt; L L Schenken
Journal:  Br J Cancer       Date:  1979-05       Impact factor: 7.640
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.